Different Treatment Modalities for Oral Lichen Plan
Effectiveness of Low-Level Laser Therapy and Topical Steroid Therapy in the Management of Oral Lichen Planus
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 71515
- Faculty of dentistry, Assiut university
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients who were monitored for OLP.
- clinical and histopathological finding of OLP in accordance with van der Meij 2003.
- being over 18 years old.
Exclusion Criteria:
- Patients with systemic disorders, pregnancy, using drugs, smoking, lesions in contact with dental amalgams, and cutaneous or other mucosal involvement at the time of treatment were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Topical Steroid Therapy of Erosive oral lichen planus
topical application of 0.1% triamcinolone acetonide and photo biomodulation on erosive oral lichen planus, 3 times daily and a miconazole oral gel once daily, for 4 weeks
|
The patients were administered topical corticosteroids in the form of a 0.1% triamcinolone acetonide preparation (Kenacort TM 0.1% Abbott).
The medication was to be used 3 times every day for 4 weeks or until the lesion has healed, whichever occurs first.
After applying the gel, the patients were instructed not to consume any fluids or food for at least 1 hour.
In addition, a topical antifungal treatment consisting of Miconazole oral gel at a concentration of 2% should be applied once a day for 4 weeks
|
|
Experimental: Low-Level Laser Therapy of Erosive oral lichen planus
Photo biomodulation with laser therapy twice a week for 8 sessions over 4 weeks, utilizing a 980 nm diode laser with an output power of 300 mw.
|
First group (Group A) underwent PBM therapy using a 980 nm diode laser (elexxion nano dental laser with a flat top handpiece).
The therapy included 8 sessions for 4 weeks, with 2 sessions conducted per week, all administered by the same operator.
The energy was evenly distributed across all the mucosal lesions and the surrounding tissues within a 0.5 cm range using a spot-technique method with little overlap.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The erosion size
Time Frame: From enrollment to the end of treatment at 4 weeks"
|
The maximal diameter (mm) and width (mm) were measured perpendicularly using a calibrated periodontal probe
|
From enrollment to the end of treatment at 4 weeks"
|
|
The Visual Analogue Scale (VAS)
Time Frame: From enrollment to the end of treatment at 4 weeks"
|
pain ratings span from zero (indicating the absence of pain) to 10 (representing extremely intense pain) along a horizontal line values.
{ the minimum is 0 and maximum is 10 }
|
From enrollment to the end of treatment at 4 weeks"
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral Health-Related Quality of Life (OHRQoL)
Time Frame: From enrollment to the end of treatment at 4 weeks"
|
A month following the initial appointment, participants were asked about the OLP that had restricted their everyday activities.
The 8 tasks included eating, talking, cleaning one's mouth, sleeping, smiling, laughing freely, maintaining emotional stability, performing strenuous physical labour, and interacting with others.
{ the minimum is 0 and maximum values is 5 }.a score of zero indicated never being afflicted, a score of 1 meant once a month, a score of 2 meant twice a month, scoring 3 indicated a frequency of once or twice weekly, 4 indicated 3 to 4 times weekly, and 5 signified daily or very daily occurrences.
|
From enrollment to the end of treatment at 4 weeks"
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Ahmed F. Assistant Professor, PhD, Faculty of Dentistry, Assiut University, Egypt
- Principal Investigator: Rahma M. Lecturer, PhD, Faculty of Dentistry, Assiut University, Egypt
- Study Chair: Asem K. Lecturer, PhD, Dental Medicine Faculty, Al-Azhar University (Assiut Branch), Assiut, Egypt
- Study Director: Mahmoud A. Professor, PhD, Faculty of Dentistry, Al-Azhar University (Assiut Branch), Assiut, Egypt.
Publications and helpful links
General Publications
- van der Meij EH, Schepman KP, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Aug;96(2):164-71. doi: 10.1016/s1079-2104(03)00305-6.
- Ruiz Roca JA, Lopez Jornet P, Gomez Garcia FJ, Marcos Aroca P. Effect of Photobiomodulation on Atrophic-Erosive Clinical Forms of Oral Lichen Planus: A Systematic Review. Dent J (Basel). 2022 Nov 27;10(12):221. doi: 10.3390/dj10120221.
- Bhatt G, Gupta S, Ghosh S. Comparative efficacy of topical aloe vera and low-level laser therapy in the management of oral lichen planus: a randomized clinical trial. Lasers Med Sci. 2022 Apr;37(3):2063-2070. doi: 10.1007/s10103-021-03480-1. Epub 2021 Dec 1.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mouth Diseases
- Stomatognathic Diseases
- Lichenoid Eruptions
- Skin Diseases, Papulosquamous
- Skin Diseases
- Lichen Planus, Oral
- Lichen Planus
- Immunosuppressive Agents
- Immunologic Factors
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Inflammatory Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Enzyme Inhibitors
- Triamcinolone
- Triamcinolone Acetonide
- Triamcinolone hexacetonide
- Triamcinolone diacetate
Other Study ID Numbers
Other Study ID Numbers
- Management of Oral Lichen Plan
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.